RJFSA
VAXX

Raymond James Financial Services Advisors’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,170
Closed -$8.01K – 3556
2024
Q1 		$8.01K Sell
11,170
-7,325
-40% -$5.31K ﹤0.01% 3376
2023
Q4 		$15.7K Sell
18,495
-164
-0.9% -$158 ﹤0.01% 3246
2023
Q3 		$25.6K Buy
18,659
+1,658
+10% +$3.59K ﹤0.01% 3183
2023
Q2 		$42.8K Buy
17,001
+6,985
+70% +$14.8K ﹤0.01% 3140
2023
Q1 		$22.7K Buy
+10,016
New +$25.4K ﹤0.01% 3173

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Raymond James Financial Services Advisors's VAXX Position: Q2 2024 in Review

Raymond James Financial Services Advisors sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 11,170 shares — an estimated $8.01K sold.

Raymond James Financial Services Advisors first reported a position in VAXX in Q1 2023 and held it in 5 quarters. The position peaked at $42.8K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Raymond James Financial Services Advisors reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 11,170 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $8.01K.
  • Raymond James Financial Services Advisors first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2023 and held it in 5 quarters.
  • Raymond James Financial Services Advisors's Vaxxinity, Inc. Class A Common Stock position peaked at $42.8K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.